HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Evgenia Dolgova Selected Research

Experimental Neoplasms

1/2022Chronometric Administration of Cyclophosphamide and a Double-Stranded DNA-Mix at Interstrand Crosslinks Repair Timing, Called "Karanahan" Therapy, Is Highly Efficient in a Weakly Immunogenic Lewis Carcinoma Model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Evgenia Dolgova Research Topics

Disease

1Carcinoma (Carcinomatosis)
01/2022
1Neoplasms (Cancer)
01/2022
1Experimental Neoplasms
01/2022

Drug/Important Bio-Agent (IBA)

1Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2022
1DNA (Deoxyribonucleic Acid)IBA
01/2022

Therapy/Procedure

1Injections
01/2022
1Therapeutics
01/2022